Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach

Karolina Drożdż,Katarzyna Nabrdalik,Hanna Kwiendacz,Mirela Hendel,Anna Olejarz,Andrzej Tomasik,Wojciech Bartman,Jakub Nalepa,Janusz Gumprecht,Gregory Y. H. Lip
DOI: https://doi.org/10.1186/s12933-022-01672-9
IF: 8.949
2022-11-13
Cardiovascular Diabetology
Abstract:Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty liver disease (MAFLD) and CVD risk has been poorly investigated. Data-driven machine learning (ML) techniques may be beneficial in discovering the most important risk factors for CVD in patients with MAFLD.
cardiac & cardiovascular systems,endocrinology & metabolism
What problem does this paper attempt to address?